NXL Stock Analysis: Buy, Sell, or Hold?
NXL - Nexalin Technology, Inc. Common Stock
$0.37
-0.03 (-6.36%)
▼
5d:
-22.12%
30d:
+14.64%
90d:
-6.88%
WAIT
LOW Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When NXL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NXL is down 22.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NXL is down 22.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NXL is currently trading at $0.37, which is considered slightly low relative to its 30-day fair value range of $0.36 to $0.54.
Technical Outlook: Technically, NXL is in a strong downtrend. The price is currently testing key support at $0.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+443.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NXL is in a strong downtrend. The price is currently testing key support at $0.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+443.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.36 -
$0.54
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading 443.5% below Wall St target ($2.00)
- WARNING: Recommendation downgraded due to -22.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.36 -
$0.54
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.44
Resistance Level
$0.64
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.19
Wall Street Target
$2.00
(+443.5%)
Revenue Growth (YoY)
-63.6%
Share & Embed Analysis
Last updated: June 21, 2026 5:29 PM ET
Data refreshes hourly during market hours. Next update: 6:29 PM
Data refreshes hourly during market hours. Next update: 6:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 60 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 56 HOLD |
